companydata.dkcompanydata.dk

MV 2017 IVS: Financial statements 2019

CVR: 38569279

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

MV 2017 IVS (CVR 38569279) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 1,329. The solvency ratio was 100%.

Equity
DKK 1,329
Total Assets
DKK 1,329

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--01 t.-
2018-001 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Mountain View IVS changes name to MV 2017 IVSDec 10, 2019

On December 10, 2019, the company changed its name from Mountain View IVS to MV 2017 IVS.

Per Arberg Jensen joins MV 2017 IVS as adm. dir.Dec 1, 2019

As of December 1, 2019, Per Arberg Jensen is registered as adm. dir. of MV 2017 IVS.

Karin Magdalena Frimodt Jensen steps down as adm. dir. of MV 2017 IVSDec 1, 2019

As of December 1, 2019, Karin Magdalena Frimodt Jensen has stepped down as adm. dir. of MV 2017 IVS.

Centret Tro Klinik for Alternativ Behandling IVS changes name to Mountain View IVSDec 1, 2019

On December 1, 2019, the company changed its name from Centret Tro Klinik for Alternativ Behandling IVS to Mountain View IVS.

MV 2017 IVS: The 2018 annual report is outJun 18, 2019

MV 2017 IVS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK 0.

About MV 2017 IVS

MV 2017 IVS was a Danish company of the type Iværksætterselskab based in Herning, founded in 2017. The company has been dissolved on 26 November 2020. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named Mountain View IVS and Centret Tro Klinik for Alternativ Behandling IVS. In 2019, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 1,329.

Source: annual report 2019, Danish Business Authority

Other financial years